Niclas Eriksson
Statistician at UCR-Uppsala Clinical Research center
- Telephone:
- +46 18 611 95 16
- E-mail:
- Niclas.Eriksson@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Niclas Eriksson at UCR-Uppsala Clinical Research center
More information is available to staff who log in.
Publications
Recent publications
- Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs (2024)
- Identification of risk factors for adverse drug reactions in a pharmacovigilance database (2023)
- Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease (2023)
- Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy (2023)
- Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21) (2023)
All publications
Articles
- Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs (2024)
- Identification of risk factors for adverse drug reactions in a pharmacovigilance database (2023)
- Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease (2023)
- Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy (2023)
- Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21) (2023)
- Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets (2023)
- Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events (2022)
- Risk of Revision After Arthroplasty Associated withSpecific Gene Loci (2022)
- Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate (2022)
- Similar risk of cancer in patients younger than 55 years with or without a total hip arthroplasty (THA) (2022)
- Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease (2022)
- Serum Neurofilament Light Chain in Patients With Atrial Fibrillation (2022)
- AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis (2022)
- Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients (2022)
- Genetic Landscape of the ACE2 Coronavirus Receptor (2022)
- HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease (2022)
- Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors (2021)
- Patient-reported Outcome in Surgically Treated Pelvic Ring Injuries at 5 Years Post-surgery (2021)
- Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate (2021)
- Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19 (2021)
- Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy (2021)
- Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis (2021)
- Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality (2021)
- Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease (2021)
- Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis (2021)
- Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations (2020)
- Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals (2020)
- No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis (2020)
- MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis (2020)
- Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data (2020)
- Exome sequencing reveals common and rare variants in F5 associated with ACE inhibitor and angiotensin receptor blocker-induced angioedema (2020)
- Next-Generation Sequencing of CYP2C19 in Stent Thrombosis (2020)
- Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. (2020)
- Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival (2019)
- Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes (2019)
- Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention (2019)
- A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture (2019)
- Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes (2019)
- Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events (2019)
- Subsequent Event Risk in Individuals With Established Coronary Heart Disease (2019)
- Novel Cyp2C19 Genetic Variants associated with Stent Thrombosis (2018)
- Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. (2018)
- Genome‐Wide Association Study of Pandemrix‐Induced Narcolepsy in Sweden – A Possible Role for Glial Derived Neurotrophic Factor (GDNF) (2018)
- Whole exome sequencing in individuals with statin-induced myopathy (2017)
- Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough (2017)
- Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease (2017)
- Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose (2016)
- The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals (2016)
- Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range (2016)
- Genetic variants associated with antithyroid drug-induced agranulocytosis (2016)
- Estimating pre-traumatic quality of life in patients with surgically treated acetabular fractures and pelvic ring injuries (2016)
- Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome (2016)
- Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome (2015)
- NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO) (2015)
- Effect of genetic variations on ticagrelor plasma levels and clinical outcomes (2015)
- Association of cyclooxygenase-2 genetic variant with cardiovascular disease (2014)
- Waran doseras bättre efter genanalys (2014)
- Polymorphism of the cystatin C gene in patients with acute coronary syndromes (2014)
- Large-scale association analysis identifies new risk loci for coronary artery disease (2013)
- Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding (2013)
- A Randomized Trial of Genotype-Guided Dosing of Warfarin (2013)
- Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin (2013)
- Prediction of warfarin dose (2012)
- Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy (2012)
- Graft Loss Risk in Renal Transplant Recipients with Metabolic Syndrome (2012)
- Anticoagulation control in Sweden (2011)
- Association of Admission Blood Glucose and Outcome in Patients Treated With Intravenous Thrombolysis (2010)
- Warfarin pharmacogenetics (2010)
- Estimation of the warfarin dose with clinical and pharmacogenetic data (2009)
- Metabolic syndrome and cardiovascular risk in renal transplant recipients (2009)
- A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose (2009)
- The largest prospective warfarin-treated cohort supports genetic forecasting (2009)
- Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) (2008)
- Surgical and long-term mortality in 2634 consecutive patients operated on the proximal thoracic aorta (2007)
- Association of warfarin dose with genes involved in its action and metabolism (2007)
- The Swedish Heart Surgery Register (2006)
- Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing (2005)
- Common VKORC1 and GGCX polymorphisms associated with warfarin dose (2005)
- A two-step proteomic approach identifies candidate biomarker in ulcerative colitis with concomitant primary sclerosing cholangitis.
- Novel biomarkers detected by proteomics predict death and cardiovascular events in hemodialysis patients
- Network-Based Analysis of Protein Interactions among Drugs and Adverse Reactions: Identifying Phenotype-Groupings and Key Genes